Showing results (2021-2030 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|March 30, 2006
Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysisSalvatore Gentile
Drug Safety|August 27, 2005
Drug-induced hypomagnesaemia : scope and managementJacob Atsmon, Eran Dolev
Drug Safety|June 1, 2005
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance databaseRoberto Leone, Anita Conforti, Mauro Venegoni, et al.
Drug Safety|June 21, 2005
From the Uppsala monitoring centre: a review of viewpoint part 1 and part 2Bruce Hugman
Drug Safety|April 28, 2005
Chemotherapy-induced ovarian failure: manifestations and managementJulian R Molina, Debra L Barton, Charles L Loprinzi
Drug Safety|September 27, 2005
Data mining in pharmacovigilance: the need for a balanced perspectiveManfred Hauben, Vaishali Patadia, Charles Gerrits, et al.
Drug Safety|September 27, 2005
Benefit-risk assessment of levetiracetam in the treatment of partial seizuresBassel Abou-Khalil
Drug Safety|September 27, 2005
Testing and implementing signal impact analysis in a regulatory setting: results of a pilot studyEmma Heeley, Patrick Waller, Jane Moseley
Drug Safety|September 27, 2005
Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reportingKarin Hedenmalm, Eva Samuelsson
Drug Safety|September 27, 2005
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitorsLois La Grenade, Lauren Lee, Joyce Weaver, et al.
Pageof 311